(Q37066194)

English

Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study

scientific article published on 17 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Richard M A Follows

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Neil G Snowise

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Shu-Yen Ho

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Claire L Ambery

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Kevin Smart

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Barbara A McQuade

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

publication date

17 May 2013

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Respiratory Research

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

54

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti-inflammatory 5-lipoxygenase-activating protein inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

LTB4 is a signal-relay molecule during neutrophil chemotaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Montelukast for the treatment of asthma in the adult population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Role of the LTB4/BLT1 pathway in allergen-induced airway hyperresponsiveness and inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

The role of leukotrienes in asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Benefit-risk assessment of antileukotrienes in the management of asthma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Prostaglandins and leukotrienes: advances in eicosanoid biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

29 September 2017

Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732081

4 September 2018

High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23682661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23682661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids

1 reference

https://pubmed.ncbi.nlm.nih.gov/23682661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/23682661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23682661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophilic inflammation in severe persistent asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23682661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1465-9921-14-54

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37066194&oldid=2199824309"